The First Fully AI-Generated Drug Enters Clinical Trials in Human Patients
“The first drug fully generated by artificial intelligence entered clinical trials with human patients this week,” reports CNBC:
Insilico Medicine, a Hong Kong-based biotech startup with more than $400 million in funding, created the drug, INS018_055,…
